Cargando…
The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis
BACKGROUND: Thyrotoxic periodic paralysis (TPP) is a life-threatening channelopathy manifesting as recurrent episodes of hypokalemia and muscle weakness in the presence of hyperthyroidism. Recent findings indicate defects of inward rectifying K+ (Kir) channels are associated with some TPP patients....
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371807/ https://www.ncbi.nlm.nih.gov/pubmed/25885757 http://dx.doi.org/10.1186/s12883-015-0290-8 |
_version_ | 1782363101241278464 |
---|---|
author | Li, Xiaobing Yao, Sheng Xiang, Yining Zhang, Xiaolei Wu, Xiangbing Luo, Laimin Huang, Haihua Zhu, Min Wan, Hui Hong, Daojun |
author_facet | Li, Xiaobing Yao, Sheng Xiang, Yining Zhang, Xiaolei Wu, Xiangbing Luo, Laimin Huang, Haihua Zhu, Min Wan, Hui Hong, Daojun |
author_sort | Li, Xiaobing |
collection | PubMed |
description | BACKGROUND: Thyrotoxic periodic paralysis (TPP) is a life-threatening channelopathy manifesting as recurrent episodes of hypokalemia and muscle weakness in the presence of hyperthyroidism. Recent findings indicate defects of inward rectifying K+ (Kir) channels are associated with some TPP patients. The associations are not only found in Caucasian population (mainly Brazilian), but also in Singaporean population. However, potential genetic risk factors for mainland Chinese patients, the largest group of TPP cases in the world, have been largely unexplored. METHODS: Samples of DNA from 127 individuals with TPP and 102 hyperthyroidism male controls self-reported as mainland Chinese were collected from 5 clinical centers from Jan 2011 to Jan 2014. The KCNJ2 gene, KCNJ18 gene, as well as loci polymorphisms (rs623011and rs312691) at 17q24.3 were directly sequenced in TPP patients and controls. Clinical data were summarized from TPP participants for genotype/phenotype correlations. RESULTS: 3.1% of TPP cases harbored KCNJ18 gene mutations in mainland Chinese patients. Patients with KCNJ18 mutation had shorter attack duration, higher prevalence of muscle soreness and weakness recurrence than patients without KCNJ18 mutation. The alleles at 17q24.3 (rs623011and rs312691) were more common in patients with TPP than in controls, and therefore were significant risk factors for TPP (odds ratio, 11.94 and 10.57; 95% CI, 5.93-24.05 and 5.48-20.40; P = 1.81 × 10(−14) and 1.07 × 10(−14) respectively). CONCLUSIONS: This study demonstrates that the KCNJ18 variants are only responsible for a small proportion of TPP patients in mainland China. There are significant clinical differences between patients with KCNJ18 mutations and patients without KCNJ18 mutations. In addition, the rs623011and rs312691 loci are significantly associated with TPP patients in mainland China, and highlight the Kir2.1 channel as a causative target in TPP. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12883-015-0290-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4371807 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43718072015-03-25 The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis Li, Xiaobing Yao, Sheng Xiang, Yining Zhang, Xiaolei Wu, Xiangbing Luo, Laimin Huang, Haihua Zhu, Min Wan, Hui Hong, Daojun BMC Neurol Research Article BACKGROUND: Thyrotoxic periodic paralysis (TPP) is a life-threatening channelopathy manifesting as recurrent episodes of hypokalemia and muscle weakness in the presence of hyperthyroidism. Recent findings indicate defects of inward rectifying K+ (Kir) channels are associated with some TPP patients. The associations are not only found in Caucasian population (mainly Brazilian), but also in Singaporean population. However, potential genetic risk factors for mainland Chinese patients, the largest group of TPP cases in the world, have been largely unexplored. METHODS: Samples of DNA from 127 individuals with TPP and 102 hyperthyroidism male controls self-reported as mainland Chinese were collected from 5 clinical centers from Jan 2011 to Jan 2014. The KCNJ2 gene, KCNJ18 gene, as well as loci polymorphisms (rs623011and rs312691) at 17q24.3 were directly sequenced in TPP patients and controls. Clinical data were summarized from TPP participants for genotype/phenotype correlations. RESULTS: 3.1% of TPP cases harbored KCNJ18 gene mutations in mainland Chinese patients. Patients with KCNJ18 mutation had shorter attack duration, higher prevalence of muscle soreness and weakness recurrence than patients without KCNJ18 mutation. The alleles at 17q24.3 (rs623011and rs312691) were more common in patients with TPP than in controls, and therefore were significant risk factors for TPP (odds ratio, 11.94 and 10.57; 95% CI, 5.93-24.05 and 5.48-20.40; P = 1.81 × 10(−14) and 1.07 × 10(−14) respectively). CONCLUSIONS: This study demonstrates that the KCNJ18 variants are only responsible for a small proportion of TPP patients in mainland China. There are significant clinical differences between patients with KCNJ18 mutations and patients without KCNJ18 mutations. In addition, the rs623011and rs312691 loci are significantly associated with TPP patients in mainland China, and highlight the Kir2.1 channel as a causative target in TPP. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12883-015-0290-8) contains supplementary material, which is available to authorized users. BioMed Central 2015-03-21 /pmc/articles/PMC4371807/ /pubmed/25885757 http://dx.doi.org/10.1186/s12883-015-0290-8 Text en © Li et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Li, Xiaobing Yao, Sheng Xiang, Yining Zhang, Xiaolei Wu, Xiangbing Luo, Laimin Huang, Haihua Zhu, Min Wan, Hui Hong, Daojun The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis |
title | The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis |
title_full | The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis |
title_fullStr | The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis |
title_full_unstemmed | The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis |
title_short | The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis |
title_sort | clinical and genetic features in a cohort of mainland chinese patients with thyrotoxic periodic paralysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371807/ https://www.ncbi.nlm.nih.gov/pubmed/25885757 http://dx.doi.org/10.1186/s12883-015-0290-8 |
work_keys_str_mv | AT lixiaobing theclinicalandgeneticfeaturesinacohortofmainlandchinesepatientswiththyrotoxicperiodicparalysis AT yaosheng theclinicalandgeneticfeaturesinacohortofmainlandchinesepatientswiththyrotoxicperiodicparalysis AT xiangyining theclinicalandgeneticfeaturesinacohortofmainlandchinesepatientswiththyrotoxicperiodicparalysis AT zhangxiaolei theclinicalandgeneticfeaturesinacohortofmainlandchinesepatientswiththyrotoxicperiodicparalysis AT wuxiangbing theclinicalandgeneticfeaturesinacohortofmainlandchinesepatientswiththyrotoxicperiodicparalysis AT luolaimin theclinicalandgeneticfeaturesinacohortofmainlandchinesepatientswiththyrotoxicperiodicparalysis AT huanghaihua theclinicalandgeneticfeaturesinacohortofmainlandchinesepatientswiththyrotoxicperiodicparalysis AT zhumin theclinicalandgeneticfeaturesinacohortofmainlandchinesepatientswiththyrotoxicperiodicparalysis AT wanhui theclinicalandgeneticfeaturesinacohortofmainlandchinesepatientswiththyrotoxicperiodicparalysis AT hongdaojun theclinicalandgeneticfeaturesinacohortofmainlandchinesepatientswiththyrotoxicperiodicparalysis AT lixiaobing clinicalandgeneticfeaturesinacohortofmainlandchinesepatientswiththyrotoxicperiodicparalysis AT yaosheng clinicalandgeneticfeaturesinacohortofmainlandchinesepatientswiththyrotoxicperiodicparalysis AT xiangyining clinicalandgeneticfeaturesinacohortofmainlandchinesepatientswiththyrotoxicperiodicparalysis AT zhangxiaolei clinicalandgeneticfeaturesinacohortofmainlandchinesepatientswiththyrotoxicperiodicparalysis AT wuxiangbing clinicalandgeneticfeaturesinacohortofmainlandchinesepatientswiththyrotoxicperiodicparalysis AT luolaimin clinicalandgeneticfeaturesinacohortofmainlandchinesepatientswiththyrotoxicperiodicparalysis AT huanghaihua clinicalandgeneticfeaturesinacohortofmainlandchinesepatientswiththyrotoxicperiodicparalysis AT zhumin clinicalandgeneticfeaturesinacohortofmainlandchinesepatientswiththyrotoxicperiodicparalysis AT wanhui clinicalandgeneticfeaturesinacohortofmainlandchinesepatientswiththyrotoxicperiodicparalysis AT hongdaojun clinicalandgeneticfeaturesinacohortofmainlandchinesepatientswiththyrotoxicperiodicparalysis |